| Platelet inhibition with cangrelor in patients undergoing PCI RA Harrington, GW Stone, S McNulty, HD White, AM Lincoff, CM Gibson, ... New England Journal of Medicine 361 (24), 2318-2329, 2009 | 738 | 2009 |
| Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial S James, A Budaj, P Aylward, KK Buck, CP Cannon, JH Cornel, ... Circulation 122 (11), 1056-1067, 2010 | 523 | 2010 |
| Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial ZC Jing, K Parikh, T Pulido, C Jerjes-Sanchez, RJ White, R Allen, ... Circulation 127 (5), 624-633, 2013 | 383 | 2013 |
| Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial J Hiremath, S Thanikachalam, K Parikh, S Shanmugasundaram, ... The Journal of heart and lung transplantation 29 (2), 137-149, 2010 | 233 | 2010 |
| Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label … E Camenzind, W Wijns, L Mauri, V Kurowski, K Parikh, R Gao, C Bode, ... The Lancet 380 (9851), 1396-1405, 2012 | 180 | 2012 |
| Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study S Banai, S Ben Muvhar, KH Parikh, A Medina, H Sievert, A Seth, J Tsehori, ... Journal of the American College of Cardiology 49 (17), 1783-1789, 2007 | 153 | 2007 |
| Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions: the ORBIT I trial K Parikh, P Chandra, N Choksi, P Khanna, J Chambers Catheterization and Cardiovascular Interventions 81 (7), 1134-1139, 2013 | 139 | 2013 |
| Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter. B Chevalier, M Gilard, I Lang, P Commeau, J Roosen, M Hanssen, ... Eurointervention: Journal of Europcr in Collaboration with the Working Group …, 2008 | 83 | 2008 |
| Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT … W Wijns, PG Steg, L Mauri, V Kurowski, K Parikh, R Gao, C Bode, ... European heart journal 35 (40), 2812-2820, 2014 | 78 | 2014 |
| Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type E Camenzind, E Boersma, W Wijns, L Mauri, T Rademaker-Havinga, ... European heart journal 35 (29), 1932-1948, 2014 | 58 | 2014 |
| Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome G Batra, TG Lakic, J Lindbäck, C Held, HD White, RAH Stewart, W Koenig, ... JAMA cardiology 6 (12), 1440-1445, 2021 | 57 | 2021 |
| Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent … E Camenzind, W Wijns, L Mauri, E Boersma, K Parikh, V Kurowski, R Gao, ... American heart journal 158 (6), 902-909. e5, 2009 | 57 | 2009 |
| Wireless acoustic communication with a miniature pressure sensor in the pulmonary artery for disease surveillance and therapy of patients with congestive heart failure Y Rozenman, RS Schwartz, H Shah, KH Parikh Journal of the American College of Cardiology 49 (7), 784-789, 2007 | 56 | 2007 |
| Cangrelor with and without glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention M Vaduganathan, RA Harrington, GW Stone, EN Deliargyris, PG Steg, ... Journal of the American College of Cardiology 69 (2), 176-185, 2017 | 55 | 2017 |
| Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning KH Parikh, MC Chag, KJ Shah, UG Shah, HA Baxi, AH Chandarana, ... Canadian journal of physiology and pharmacology 85 (3-4), 476-482, 2007 | 49 | 2007 |
| Effect of diltiazem on renal clearance and serum concentration of digoxin in patients with cardiac disease U Elkayam, K Parikh, B Torkan, L Weber, JL Cohen, SH Rahimtoola The American journal of cardiology 55 (11), 1393-1395, 1985 | 45 | 1985 |
| Long-term safety and performance of the orbital atherectomy system for treating calcified coronary artery lesions: 5-Year follow-up in the ORBIT I trial P Bhatt, P Parikh, A Patel, M Chag, A Chandarana, R Parikh, K Parikh Cardiovascular Revascularization Medicine 16 (4), 213-216, 2015 | 40 | 2015 |
| Orbital atherectomy system in treating calcified coronary lesions: 3-Year follow-up in first human use study (ORBIT I trial) P Bhatt, P Parikh, A Patel, M Chag, A Chandarana, R Parikh, K Parikh Cardiovascular Revascularization Medicine 15 (4), 204-208, 2014 | 39 | 2014 |
| Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED‐HF) JJV McMurray, IS Anand, R Diaz, AP Maggioni, C O'Connor, MA Pfeffer, ... European journal of heart failure 15 (3), 334-341, 2013 | 37 | 2013 |
| Unique aspects of coronary artery disease in Indian women P Bhatt, P Parikh, A Patel, R Parikh, A Patel, JL Mehta, K Parikh Cardiovascular drugs and therapy 29, 369-376, 2015 | 24 | 2015 |
